H eart failure (HF) is a significant public health problem that affects an estimated 5.7 million American adults and is associated with increased morbidity, mortality, and healthcare cost. 1, 2 Despite important advances in medical and device therapies over the past 2 decades, outcomes associated with HF remain poor, highlighting the need for effective preventive strategies. 3, 4 An important first step in HF prevention is to identify the intermediate at-risk phenotypes that play a constitutive role in pathogenesis of HF and may be targeted with novel preventive therapies. Previous studies have demonstrated that progression from at-risk to symptomatic HF stage occurs through a series of intermediate cardiac phenotypes characterized by left ventricular (LV) remodeling (ie, concentric LV hypertrophy and eccentric LV hypertrophy), changes in systolic function (ie, ejection fraction [EF] and strain), and diastolic function. February 2017 (CVD) and mortality. [16] [17] [18] [19] Furthermore, cross-sectional studies have demonstrated higher arterial stiffness among HF patients compared with hypertensive adults. 12, [20] [21] [22] [23] [24] However, the contributions of increased arterial stiffness, independent of other established risk factors, on the risk of incident HF and its subtypes are not well established. This is largely because of conflicting findings from previous cohorts and lack of adequate power to assess HFpEF and HFrEF outcomes. 19, 25 In this study, we evaluated the association between measures of cf-PWV and risk of HF, HFpEF, and HFrEF in a communitybased cohort of well-functioning older adults.
Methods

Study Population
The Health ABC study (Health, Aging, and Body Composition) is a prospective cohort study of community-dwelling older adults that evaluated the impact of changes in weight and body composition on age-related physiological and functional changes. The details of the study design, participant eligibility criteria, and recruitment strategy have been reported previously. 26 Briefly, well-functioning adults aged 70 to 79 years who were free of life-threatening illnesses and could perform daily activities of living without difficulty were recruited between March 1987 and July 1998 from a random sample of white and all black Medicare beneficiaries residing around Pittsburgh and Memphis. The study participants underwent detailed examination at baseline and subsequent annual follow-up visits for first 6 years. Participants also had detailed telephone interviews every 6 months. All study participants provided written informed consent. Institutional Review Boards at the University of Tennessee and University of Pittsburgh approved the study protocols. Of the 3075 participants who were initially enrolled in the Health ABC study, baseline measures of cf-PWV were available in 2488 participants. For the present study, we further excluded 111 participants with prevalent HF and 87 participants with missing covariates of interest at baseline. The final study population consisted of 2290 participants. The baseline characteristics of study participants with versus without cf-PWV measures have been compared previously.
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Health ABC Baseline Examination and Covariate Definitions
Details about baseline examination, laboratory tests protocols, and variable definitions for the Health ABC study have been described previously. [26] [27] [28] Information on demographic characteristics, including age, sex, ethnicity, education level, smoking, and alcohol use, was self-reported. Prevalent comorbidities such as diabetes mellitus and hypertension were assessed based on self-reported physician diagnosis and confirmed by use of specific medications, or positive examination, or laboratory tests. Exercise and physical activity levels were also self-reported and estimated in kilocalories per week using a standardized questionnaire. 29 Prevalent CVD included coronary heart disease (CHD) identified based on history of myocardial infarction, angina, or coronary revascularization; cerebrovascular disease identified based on history of stroke, transient ischemic attack, or carotid endarterectomy; or peripheral vascular disease identified by history of intermittent claudication or peripheral vascular procedures.
Assessment of Central Arterial Stiffness
cf-PWV, a gold-standard measure of arterial stiffness, 30 was measured noninvasively using a well-established, highly reproducible technique that has been reported previously. 19, 31 Higher measures of cf-PWV reflect higher central arterial stiffness. Nondirectional transcutaneous Doppler flow probes (model 810A, 9.0-to 10.0-MHz Probes; Parks Medical Electronics, Inc) were used to obtain Doppler flow signals from right carotid and femoral arteries. For each participant, the data were recorded for 3 runs, each with at least 10 pairs of simultaneous flow waves, and then averaged. A metal tape was used to measure the distance between the ipsilateral carotid and femoral artery above the body surface. cf-PWV was calculated as the ratio of the distance between the carotid and femoral arteries and the time differential between the onset of flow at carotid and femoral (defined as foot of the pressure tracing at each site) sites. The National Institute on Aging, Laboratory of Cardiovascular Science, Gerontology Research Center (Baltimore, MD) trained and certified all study personnel before data collection, read the waveforms, and evaluated data quality. As reported previously, cf-PWV measures demonstrated high degree of reproducibility with an interclass correlation coefficient of 0.88 between sonographers and 0.84 between readers.
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Heart Failure Outcomes Assessment
The study participants were contacted every 6 months to obtain information about interval adverse cardiovascular events. 26 Incident HF was identified by hospitalizations related to HF among participants without prevalent HF at baseline. The HF diagnosis was clinically adjudicated and confirmed based on the review of index hospitalization records using criteria similar to those from the Cardiovascular Health Study. 33 These criteria required a physician diagnosis of HF with documentation of HF symptoms and signs, supportive radiological findings, and medical therapy for HF, including use of a diuretic agent and either digitalis or vasodilator or β-blocker. 34 A subset of HF cases had EF data available, which was used to identify cases of incident HFpEF (EF >45%) and HFrEF (EF ≤45%). 35 The EF cutoff used for HFpEF and HFrEF diagnosis is consistent with that used in other longitudinal cohort studies and large-scale randomized controlled trials on HFpEF patients.
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Statistical Analysis
The study participants were stratified into tertiles of baseline measures of cf-PWV. Descriptive analyses were performed, and data are presented as mean (standard deviation) for continuous and percentage for categorical variables. Baseline clinical and demographic characteristics were compared across the 3 groups using the Chi-square test for categorical variables and Kruskal-Wallis test for continuous variables. Nelson-Aalen estimates of the cumulative hazard function were plotted to assess and compare the unadjusted cumulative risk of overall HF, HFpEF, and HFrEF across the cf-PWV tertiles. Multivariable adjusted Cox-proportional hazards models were constructed to determine the association between categorical (tertiles) and continuous measures of cf-PWV and different HF outcomes with adjustment for the following covariates: model 1-age and sex; model 2-model 1+ethnicity, heart rate, and mean arterial pressure; model 3-model 2+body mass index, prevalent CHD, antihypertensive use, education status, diabetes mellitus status, smoking, drinking status, physical activity, and renal function. Systolic blood pressure was not included as a covariate in the adjusted models because it is often a consequence of arterial stiffness in the pathogenesis of HF. Separate models were constructed for overall HF, HFpEF, and HFrEF outcomes. Proportional hazards assumption of the Cox models was assessed and satisfied for the study outcomes. Death was treated as a censoring event in these models. Owing to the skewed distribution of cf-PWV in the study population, the variable was log-transformed for continuous Cox-proportional hazards models.
A sensitivity analysis was performed treating death as a competing risk, with additional adjustment for incident CHD on follow-up as a time varying covariate in model 3. Sensitivity analyses were also performed excluding participants with baseline CVD and without adjustment for heart rate and antihypertensive use because these characteristics may have a more mediatory role in the relationship between cf-PWV and incident HF. All statistical analyses were performed using SATA version 12 (Stata Corp, College Station, TX).
Results
We included 2290 participants in our study (53% women and 35% blacks). The baseline characteristics of the study participants are compared across tertiles of cf-PWV in Table 1 . Higher cf-PWV was associated with black race, prevalent CVD, and prevalent CVD risk factors (hypertension and diabetes mellitus). Blood pressure, resting heart rate, and body mass index were also significantly higher among participants with higher cf-PWV. We observed 390 incident HF events over a median follow-up of 11.4 years, of which 41.5% were HFpEF, 37.2% were HFrEF, and 21.3% were unclassified HF.
Association Between cf-PWV Categories and Risk of Overall HF
In unadjusted comparisons, higher cf-PWV was associated with increased risk of HF (P value <0.0001; Figure 1) , with the highest risk among tertile 3 participants. The cumulative hazard function curves indicate a threshold effect between tertiles 2 and 3 for HF risk. Table 2 shows the multivariable adjusted association between categorical measures of cf-PWV and risk of HF. After adjustment for age and sex, higher measures of cf-PWV were significantly associated with higher risk of HF (model 1). This association was slightly attenuated but remained significant after additional adjustment for ethnicity, heart rate, and mean arterial blood pressure (model 2). Further adjustment for additional risk factors attenuated this relationship significantly, such that cf-PWV was no longer associated with HF risk (model 3)
Association Between cf-PWV Categories and Risk of HF Subtypes
In unadjusted analysis, higher cf-PWV was associated with higher risk of both HFpEF and HFrEF (P value: 0.02 for both; Figure 2 ), with the highest risk among tertile 3 participants. In adjusted analysis, higher cf-PWV was significantly associated with higher risk of HFrEF and HFpEF after adjustment for age and sex (model 1; Table 3 ). This association attenuated significantly and was no longer significant after further adjustment for ethnicity, heart rate, mean arterial blood pressure (model 2; Table 3 ), and other risk factors (model 3; Table 3 ).
Association Between Continuous Measures of cf-PWV and Risk of HF Outcomes
The continuous association between cf-PWV and risk of HF, HFpEF, and HFrEF were assessed in separate Coxproportional hazards models using log-transformed measures of cf-PWV. We observed a progressive attenuation in the association between cf-PWV and risk of HF, HFpEF, and HFrEF, with sequential adjustment for potential confounders, similar to that observed in categorical analysis. Higher cf-PWV was not associated with risk of HF outcomes in the most adjusted model (Figure 3) . Furthermore, no significant interaction was observed between participant characteristics, such as body mass index, physical activity levels, and cf-PWV for risk of HF (P interaction >0.2 for all; Figure S1 in the online-only Data Supplement).
Sensitivity Analysis
Sensitivity analysis was performed to evaluate the association between measures of cf-PWV and risk of HF among participants without CVD at baseline and without adjustment for potential mediator characteristics, including hypertension status and heart rate, in the final model. The pattern of association between cf-PWV and risk of HF in this subgroup was not different from that of the overall study population, such that higher measures of cf-PWV were not significantly associated with HF risk after adjustment for potential confounders (hazard ratio [95% confidence interval] per log 2 higher cf-PWV =1.12 [0.89-1.42]; Table S1 ).
Of the 2290 participants included in the analysis, 1027(44.8%) died during follow up. In sensitivity analysis treating death as a competing risk with additional adjustment for incident CHD as a time-varying covariate, categorical and continuous measures of cf-PWV were not significantly associated with risk of HF outcomes (Table S2) .
Discussion
In the present study of community-dwelling elderly individuals, we observed that higher cf-PWV was associated with greater risk of overall HF and its subtypes, HFpEF and HFrEF. However, these associations were attenuated substantially after adjustment for CVD and its risk factors. Taken together, our study findings suggest that the association between vascular remodeling and increased arterial stiffness, as measured by cf-PWV, and HF risk in older adults may be related to the burden of coexistent CVD or risk factors.
Higher measures of arterial stiffness have been associated with greater risk of major adverse cardiovascular events, including MI, incident coronary artery disease, and mortality. [16] [17] [18] [19] A previous analysis from the Health ABC study with 181 HF events demonstrated no association between cf-PWV and HF risk, even in unadjusted analysis. 19 In contrast, in the present study with 390 HF events, we observed significant inverse association after adjustment for age, sex, ethnicity, blood pressure, and heart rate. This could be related to greater statistical power and higher number of HF events in the present analysis.
The association between arterial stiffness, as measured by cf-PWV, and HF risk has been explored in other cohort studies. Chirinos et al 40 demonstrated that higher measures of cf-PWV were associated with greater risk of HF in a cohort of chronic kidney disease patients. Recently, in a secondary analysis from the FHS (Framingham Heart Study), Tsao et al 25 demonstrated a significant association between cf-PWV and HF risk (hazard ratio [95% confidence interval], 1.29 [1.02-1.64]; P value =0.04). Findings in our study are in contrast to that from Tsao et al 25 and could be related to several factors. First, there are significant differences in the population characteristics that may influence the observed associations between measures of arterial stiffness and HF risk. The FHS population is relatively younger and racially/ ethnically homogenous as compared with the Health ABC study population. Second, the multivariable adjusted model by Tsao et al 25 did not account for many potential confounders, including heart rate, renal function, and physical activity levels. Thus, the observed association between cf-PWV and HF risk may be related to residual confounding. It is noteworthy that the association between cf-PWV and HF in the age-and sex-adjusted models was not different between the 2 studies. Finally, as noted previously, there were differences in the cf-PWV assessment methods between the Health ABC and FHS. 41 It is unclear if these differences in cf-PWV measurements may have influenced the study findings because its association with other cardiovascular outcomes is not different between the 2 cohorts.
Availability of EF information from index HF hospitalization in a substantial proportion of HF patients allowed us to evaluate the association between arterial stiffness and risk of HF subtypes, HFpEF and HFrEF. In age-and sex-adjusted models, cf-PWV was more strongly associated with HFrEF risk as compared with HFpEF risk. However, these associations were substantially attenuated and not significant after adjustment for blood pressure, heart rate, and other potential confounders. Tsao et al 25 had evaluated the association between cf-PWV and HF subtypes in the FHS and observed stronger association for HFrEF than for HFpEF, similar to our study findings. However, their study was limited in statistical power, with only 77 HFpEF and 61 HFrEF events. The present study with 162 HFpEF and 147 HFrEF events adds significantly to the existing literature, with adequate power to evaluate the association between cf-PWV and risk of HF subtypes.
Previous cross-sectional studies have reported higher arterial stiffness among patients with HFpEF as compared with hypertensive control patients. 12, 20, 42 However, there were significant differences in age, sex distribution, and other clinical characteristics that may have lead to the observed differences. In the present study, we observe that the contributions of arterial stiffness, as measured by cf-PWV, beyond differences in traditional risk factors toward risk of HF subtypes are not significant. Our findings are supported by the cross-sectional observations from Lam et al 43 who demonstrated that after adjustment for age, sex, and body size, measures of arterial stiffness were similar among HFpEF patients and hypertensive control participants.
It is noteworthy that the lack of association between cf-PWV and HF risk may not be generalizable to other measures of pulsatile hemodynamic afterload, such as reflected wave magnitude, aortic impedance, and total arterial compliance. Reflected waves and late systolic load have been associated Figure 1 . Cumulative risk of heart failure across different carotidfemoral pulse wave velocity-based study groups (cf-PW T1 through T3). Anti-HTN indicates antihypertensive medication; BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; and MAP, mean arterial pressure.
with diastolic dysfunction and adverse myocardial remodeling in animal studies. 44, 45 Similarly, several cross-sectional studies in humans have demonstrated the significant contribution of reflected waves and aortic characteristic impedance to LV systolic and diastolic dysfunction. [46] [47] [48] Furthermore, in a recent longitudinal cohort study among participants of the MESA (Multi-Ethnic Study of Atherosclerosis), Chirinos et al 49 demonstrated an independent association between reflection wave magnitude and incident HF risk. Future studies are needed to better assess the effects of afterload (reflected waves, aortic impedance, and total arterial compliance) measured directly via pressure flow relations on the risk of incident HF among older individuals.
Our study findings have important clinical implications. The higher incidence of HF outcomes among patients with elevated cf-PWV seems to be related to greater burden of CVD and its risk factors in these patients. Thus, higher arterial stiffness is an intermediate phenotype observed in at-risk individuals, but it may not contribute to development of HF, independent of other risk factors. Higher cf-PWV may be useful to identify individuals who are at increased risk of HF development and may benefit from aggressive risk factor modification. This is consistent with the hypothesis recently proposed by Paulus et al, 50 in which risk factors and comorbidity were identified as the primary determinants of HFpEF pathophysiology through their inflammatory effects.
Several important issues must be considered in regards to the overall null findings in our study. These include possibility of type II error, measurement of the exposure variable and outcomes of interest, and other potential biases. The large number of events (390 HF events) observed in our study ensures adequate statistical power to evaluate the association between cf-PWV and HF risk. Thus, a type II error is less likely in our study. The measures of cf-PWV in the Health ABC study are well established and previously validated. 19, 32 Furthermore, cf-PWV has been shown to be strongly associated with cardiovascular mortality and CHD outcomes in the Health ABC cohort, similar to other population-based cohorts. [17] [18] [19] It is possible that the observed lack of association is related to the older age and higher burden of CVD and its risk factors in our study population. The strong associations of prevalent CVD and risk factors with HF risk in this older study cohort could mask our ability to observe an independent association for cf-PWV. Finally, there is a potential for survival bias in our study of older adults, such that individuals who were more susceptible to higher arterial stiffness-related HF risk or other adverse cardiovascular events may not have survived or met the eligibility criteria Figure 2 . Cumulative risk of heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) across different carotid-femoral pulse wave velocitybased study groups (cf-PW T1 through T3). Anti-HTN indicates antihypertensive medication; BMI, body mass index; CD, coronary heart disease; CHD, coronary heart disease; CI, confidence interval; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HR, heart rate; and MAP, mean arterial pressure.
to be included in this study. Thus, the associations between arterial stiffness and HF risk may be stronger in a middle-age population.
Several other limitations to our study are noteworthy. The study population included older community-dwelling adults of black and white race, and our study findings may not be generalizable to younger population and other race/ethnicities. HF adjudication was based on inpatient hospitalization, and thus, we may have missed a proportion of HF events that were diagnosed in outpatient visits. Furthermore, we do not have baseline echocardiographic assessment in our study participants, and therefore, individuals with asymptomatic LV dysfunction or other cardiac structural abnormalities may have been included in the analysis.
Perspectives
We have demonstrated in a community-based sample of well-functioning older adults that higher arterial stiffness, as measured by cf-PWV, is not independently associated with increased risk of HF or its subtypes after adjustment for prevalent CVD and risk factors. These findings suggest that higher cf-PWV-associated risk of HF is largely mediated by coexistent disease or traditional risk factors. Future studies are needed to determine whether these findings are generalizable to other measures of LV afterload.
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